Adults with prediabetes experience a faster decline in kidney function than those with normal glucose, highlighting the need ...

Chronic Kidney Disease (CKD) is quietly rising as a global health crisis, and the latest research reveals just how serious ...

A trial evaluated whether rituximab can attain remission in adults with frequently relapsing nephrotic syndrome (FRNS) or steroid dependent nephrotic syndrome (SDNS).

CKD prevalence has more than doubled since 1990, with 788 million adults affected in 2023, highlighting a significant global health challenge. The disease is a major contributor to cardiovascular ...